DK1079834T3 - Stabile sammensætninger omfattende levosimendan og alginsyre - Google Patents
Stabile sammensætninger omfattende levosimendan og alginsyreInfo
- Publication number
- DK1079834T3 DK1079834T3 DK99916943T DK99916943T DK1079834T3 DK 1079834 T3 DK1079834 T3 DK 1079834T3 DK 99916943 T DK99916943 T DK 99916943T DK 99916943 T DK99916943 T DK 99916943T DK 1079834 T3 DK1079834 T3 DK 1079834T3
- Authority
- DK
- Denmark
- Prior art keywords
- levosimendan
- alginic acid
- stable compositions
- compositions
- stable
- Prior art date
Links
- WHXMKTBCFHIYNQ-SECBINFHSA-N levosimendan Chemical compound C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1 WHXMKTBCFHIYNQ-SECBINFHSA-N 0.000 title abstract 4
- 229960000692 levosimendan Drugs 0.000 title abstract 4
- 229960001126 alginic acid Drugs 0.000 title abstract 2
- 235000010443 alginic acid Nutrition 0.000 title abstract 2
- 229920000615 alginic acid Polymers 0.000 title abstract 2
- 239000000783 alginic acid Substances 0.000 title abstract 2
- 150000004781 alginic acids Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Jellies, Jams, And Syrups (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI980902A FI980902A7 (fi) | 1998-04-23 | 1998-04-23 | Levosimendaanin stabiileja koostumuksia |
| PCT/FI1999/000331 WO1999055337A1 (en) | 1998-04-23 | 1999-04-23 | Stabile compositions comprising levosimendan and alginic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1079834T3 true DK1079834T3 (da) | 2003-04-07 |
Family
ID=8551576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99916943T DK1079834T3 (da) | 1998-04-23 | 1999-04-23 | Stabile sammensætninger omfattende levosimendan og alginsyre |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6531458B1 (cs) |
| EP (1) | EP1079834B1 (cs) |
| JP (1) | JP4475809B2 (cs) |
| KR (1) | KR100590622B1 (cs) |
| CN (1) | CN1165309C (cs) |
| AT (1) | ATE231395T1 (cs) |
| AU (1) | AU756338B2 (cs) |
| BG (1) | BG64766B1 (cs) |
| BR (1) | BR9909867A (cs) |
| CA (1) | CA2329232C (cs) |
| CZ (1) | CZ290911B6 (cs) |
| DE (1) | DE69905034T2 (cs) |
| DK (1) | DK1079834T3 (cs) |
| EA (1) | EA002428B1 (cs) |
| EE (1) | EE04143B1 (cs) |
| ES (1) | ES2191426T3 (cs) |
| FI (1) | FI980902A7 (cs) |
| GE (1) | GEP20032942B (cs) |
| HR (1) | HRP20000703B1 (cs) |
| HU (1) | HUP0105446A3 (cs) |
| ID (1) | ID26650A (cs) |
| IL (2) | IL138950A0 (cs) |
| MX (1) | MXPA00010368A (cs) |
| NO (1) | NO318575B1 (cs) |
| NZ (1) | NZ507455A (cs) |
| PL (1) | PL192274B1 (cs) |
| PT (1) | PT1079834E (cs) |
| RS (1) | RS49955B (cs) |
| SK (1) | SK284600B6 (cs) |
| TR (1) | TR200003101T2 (cs) |
| WO (1) | WO1999055337A1 (cs) |
| ZA (1) | ZA200005630B (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI980901A7 (fi) * | 1998-04-23 | 1999-10-24 | Orion Yhtymae Oyj | Levosimendaania säädellysti vapauttavia oraalisia koostumuksia |
| FI109659B (fi) * | 1999-09-10 | 2002-09-30 | Orion Yhtymae Oyj | Levosimendaanin farmaseuttisia liuoksia |
| FI20010233A0 (fi) * | 2001-02-08 | 2001-02-08 | Orion Corp | Menetelmä sydämen vajaatoiminnan hoitoon |
| WO2002064120A1 (fr) * | 2001-02-13 | 2002-08-22 | Taisho Pharmaceutical Co., Ltd. | Preparations de gel a usage interne |
| US20080194567A1 (en) * | 2005-03-14 | 2008-08-14 | Piero Pollesello | Combination Treatment for Enhancing Diuresis |
| AU2016349408B2 (en) * | 2015-11-06 | 2021-06-03 | Carinopharm Gmbh | Improved formulations of Levosimendan for intravenous administration as infusion or injection and of infusion concentrate |
| CA3161960A1 (en) | 2019-12-16 | 2021-06-24 | Tenax Therapeutics, Inc. | Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1509866A (en) | 1975-06-10 | 1978-05-04 | Johnson & Johnson | Enteric coated digestive enzyme compositions |
| AU555304B2 (en) | 1982-04-05 | 1986-09-18 | Merck Sharp & Dohme Limited | Stabilization of drugs in alginic acid and magnesium hydroxide granules |
| EP0123291A2 (en) | 1983-04-20 | 1984-10-31 | Kyowa Hakko Kogyo Co., Ltd. | Method for stabilizing interferon |
| US4906630A (en) * | 1985-11-22 | 1990-03-06 | Rorer Pharmaceutical Corporation | Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds |
| US4716042A (en) * | 1986-06-16 | 1987-12-29 | American Home Products Corporation | Stabilized coated aspirin tablets |
| GB8903130D0 (en) | 1989-02-11 | 1989-03-30 | Orion Yhtymae Oy | Substituted pyridazinones |
| GB2251615B (en) * | 1991-01-03 | 1995-02-08 | Orion Yhtymae Oy | (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile |
| GB2266841A (en) | 1992-05-06 | 1993-11-17 | Orion Yhtymae Oy | Compounds for use as anti-ischemic medicaments |
| GB9614098D0 (en) * | 1996-07-05 | 1996-09-04 | Orion Yhtymae Oy | Transdermal delivery of levosimendan |
| FI973804A7 (fi) * | 1997-09-26 | 1999-03-27 | Orion Yhtymae Oy | Levosimendaanin oraalisia koostumuksia |
-
1998
- 1998-04-23 FI FI980902A patent/FI980902A7/fi unknown
-
1999
- 1999-04-23 PT PT99916943T patent/PT1079834E/pt unknown
- 1999-04-23 CZ CZ20003779A patent/CZ290911B6/cs not_active IP Right Cessation
- 1999-04-23 DE DE69905034T patent/DE69905034T2/de not_active Expired - Lifetime
- 1999-04-23 US US09/673,793 patent/US6531458B1/en not_active Expired - Fee Related
- 1999-04-23 DK DK99916943T patent/DK1079834T3/da active
- 1999-04-23 ES ES99916943T patent/ES2191426T3/es not_active Expired - Lifetime
- 1999-04-23 GE GEAP19995638A patent/GEP20032942B/en unknown
- 1999-04-23 KR KR1020007011789A patent/KR100590622B1/ko not_active Expired - Fee Related
- 1999-04-23 AT AT99916943T patent/ATE231395T1/de not_active IP Right Cessation
- 1999-04-23 EP EP99916943A patent/EP1079834B1/en not_active Expired - Lifetime
- 1999-04-23 SK SK1555-2000A patent/SK284600B6/sk not_active IP Right Cessation
- 1999-04-23 ID IDW20002368A patent/ID26650A/id unknown
- 1999-04-23 RS YUP-640/00A patent/RS49955B/sr unknown
- 1999-04-23 MX MXPA00010368A patent/MXPA00010368A/es active IP Right Grant
- 1999-04-23 EE EEP200000616A patent/EE04143B1/xx not_active IP Right Cessation
- 1999-04-23 WO PCT/FI1999/000331 patent/WO1999055337A1/en not_active Ceased
- 1999-04-23 IL IL13895099A patent/IL138950A0/xx active IP Right Grant
- 1999-04-23 AU AU35248/99A patent/AU756338B2/en not_active Ceased
- 1999-04-23 EA EA200001097A patent/EA002428B1/ru not_active IP Right Cessation
- 1999-04-23 NZ NZ507455A patent/NZ507455A/en unknown
- 1999-04-23 PL PL343722A patent/PL192274B1/pl not_active IP Right Cessation
- 1999-04-23 HR HR20000703A patent/HRP20000703B1/xx not_active IP Right Cessation
- 1999-04-23 TR TR2000/03101T patent/TR200003101T2/xx unknown
- 1999-04-23 CA CA002329232A patent/CA2329232C/en not_active Expired - Fee Related
- 1999-04-23 JP JP2000545535A patent/JP4475809B2/ja not_active Expired - Lifetime
- 1999-04-23 CN CNB998053805A patent/CN1165309C/zh not_active Expired - Fee Related
- 1999-04-23 BR BR9909867-9A patent/BR9909867A/pt not_active Application Discontinuation
- 1999-04-23 HU HU0105446A patent/HUP0105446A3/hu unknown
-
2000
- 2000-10-11 IL IL138950A patent/IL138950A/en not_active IP Right Cessation
- 2000-10-12 ZA ZA200005630A patent/ZA200005630B/en unknown
- 2000-10-20 NO NO20005312A patent/NO318575B1/no not_active IP Right Cessation
- 2000-11-17 BG BG104958A patent/BG64766B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60013098D1 (de) | Zusammensetzung zur hautdesinfizierung | |
| ATE376835T1 (de) | Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis | |
| NO992617L (no) | Sulfinsyrederivater, deres fremstilling og anvendelse | |
| DE60143906D1 (de) | Verwendung von derivaten der 2-oxothiazolidin-4-corbonsäure als prä-abschuppungsmittel | |
| BR9713338A (pt) | Benzonaftiridinas como terapêuticos brÈnquicos. | |
| TR199802441A3 (tr) | Kanda asiri ürik asit bulunmasinin tedavisi ve önlenmesi için yöntem ve terkip. | |
| ATE297188T1 (de) | Stabilisierte ascorbinsäure-lösungen | |
| ATE311853T1 (de) | Verwendung von krillenzymen zur behandlung von zahnbelag | |
| DE69525740D1 (de) | Spezielle halofantrinhaltige Zusammensetzungen | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| DK1079834T3 (da) | Stabile sammensætninger omfattende levosimendan og alginsyre | |
| ATE302002T1 (de) | Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit | |
| NO20003758L (no) | Trekonserveringsmidler | |
| ATE217191T1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
| DK0921806T3 (da) | Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser | |
| ATE223721T1 (de) | Edelfosin zur behandlung von hirntumoren | |
| NO20061138L (no) | Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi | |
| TR200200278T2 (tr) | Kalsilitik bileşimler | |
| DE60219940D1 (de) | Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie | |
| NO970573D0 (no) | Ylidenforbindelser og deres fremstilling | |
| DE60029624D1 (de) | Homologe enzyme der humanen heparanase sowie alternative spleissformen davon | |
| DE60034770D1 (de) | Stabile fumagillin-formulierung | |
| DE60137506D1 (de) | Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthrose | |
| ATE184155T1 (de) | Verwendung der jodwasserstoffsäure als aphrodisiakum | |
| DE50003481D1 (de) | Verwendung von schmutzablösenden formulierungen zur behandlung von oberflächen |